Oxfendazole

N/A

Report date: 2026/05/05 20:00:16
NME

Base Information

Drug NameOxfendazole
Drug Alias NameRS-8858
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase SRC inhibitors
TargetsTyrosine-protein kinase SRC
Therapy Area/IndicationsFascioliasisFilariasisTrichuriasis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTanzania
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesUniversidad Peruana Cayetano Heredia, Lima, PeruSwiss Tropical & Public Health InstituteCayetano Heredia University +[4] 
Inactive CompaniesJohns Hopkins Bloomberg School Of Public Health
Active IndicationsFascioliasisFilariasisTrichuriasis +[4] 
Inactive IndicationsHelminthiasis

Other Information

ATC CodeN/A
Related LinksN/A